Your browser doesn't support javascript.
loading
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.
Rodríguez-Arbolí, Eduardo; Martínez-Cuadrón, David; Rodríguez-Veiga, Rebeca; Carrillo-Cruz, Estrella; Gil-Cortés, Cristina; Serrano-López, Josefina; Bernal Del Castillo, Teresa; Martínez-Sánchez, María Del Pilar; Rodríguez-Medina, Carlos; Vidriales, Belén; Bergua, Juan Miguel; Benavente, Celina; García-Boyero, Raimundo; Herrera-Puente, Pilar; Algarra, Lorenzo; Sayas-Lloris, María José; Fernández, Rosa; Labrador, Jorge; Lavilla-Rubira, Esperanza; Barrios-García, Manuel; Tormo, Mar; Serrano-Maestro, Alfons; Sossa-Melo, Claudia Lucía; García-Belmonte, Daniel; Vives, Susana; Rodríguez-Gutiérrez, Juan Ignacio; Albo-López, Carmen; Garrastazul-Sánchez, María Paz; Colorado-Araujo, Mercedes; Mariz, José; Sanz, Miguel Ángel; Pérez-Simón, José Antonio; Montesinos, Pau.
Afiliação
  • Rodríguez-Arbolí E; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, Seville, Spain.
  • Martínez-Cuadrón D; Department of Hematology, Hospital Universitario La Fe, Valencia, Spain.
  • Rodríguez-Veiga R; Department of Hematology, Hospital Universitario La Fe, Valencia, Spain.
  • Carrillo-Cruz E; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, Seville, Spain.
  • Gil-Cortés C; Department of Hematology, Hospital General Universitario de Alicante, Alicante, Spain.
  • Serrano-López J; Department of Hematology, Reina Sofía University Hospital/Maimónides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba, Córdoba, Spain.
  • Bernal Del Castillo T; Department of Hematology, Hospital Central de Asturias, ISPA, IUOPA, Oviedo, Spain.
  • Martínez-Sánchez MDP; Department of Hematology, Hospital Universitario 12 de Octubre, UCM, CNIO, CIBERONC, Madrid, Spain.
  • Rodríguez-Medina C; Department of Hematology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
  • Vidriales B; Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC- CB16/12/00233 and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Bergua JM; Department of Hematology, Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Benavente C; Department of Hematology, Hospital Clínico San Carlos, Madrid, Spain.
  • García-Boyero R; Department of Hematology, Hospital General Universitario de Castellón, Castellón de la Plana, Spain.
  • Herrera-Puente P; Department of Hematology, Hospital Ramón y Cajal, Madrid, Spain.
  • Algarra L; Department of Hematology, Hospital General de Albacete, Albacete, Spain.
  • Sayas-Lloris MJ; Department of Hematology, Hospital Universitario Doctor Peset, Valencia, Spain.
  • Fernández R; Department of Hematology, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Labrador J; Department of Hematology and Research Unit, Hospital Universitario de Burgos, Burgos, Spain.
  • Lavilla-Rubira E; Department of Hematology, Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Barrios-García M; Department of Hematology, Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Tormo M; Deparment of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación INCLIVA, Valencia, Spain.
  • Serrano-Maestro A; Department of Hematology, Hospital Universitario HM Sanchinarro, Madrid, Spain.
  • Sossa-Melo CL; Fundación Oftalmológica de Santander-Clínica Carlos Ardila Lulle, Floridablanca, Colombia.
  • García-Belmonte D; Department of Hematology, Hospital Universitario La Zarzuela, Madrid, Spain.
  • Vives S; Department of Hematology - ICO Hospital Germans Trias i Pujol , Josep Carreras Leukemia Research Institute, Badalona , Spain.
  • Rodríguez-Gutiérrez JI; Department of Hematology, Basurtoko Unibertsitate Ospitalea, Bilbao, Spain.
  • Albo-López C; Department of Hematology, Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
  • Garrastazul-Sánchez MP; Department of Hematology, Hospital Universitario Puerta del Mar, Cádiz, Spain.
  • Colorado-Araujo M; Department of Hematology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Mariz J; Department of Hematology, Instituto Português de Oncologia do Porto FG, Porto, Portugal.
  • Sanz MÁ; Department of Hematology, Hospital Universitario La Fe, Valencia, Spain.
  • Pérez-Simón JA; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, Seville, Spain. Electronic address: josea.perez.simon.sspa@juntadeandalucia.es.
  • Montesinos P; Department of Hematology, Hospital Universitario La Fe, Valencia, Spain.
Transplant Cell Ther ; 27(4): 311.e1-311.e10, 2021 04.
Article em En | MEDLINE | ID: mdl-33836871
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article